Hsin-Yin (Grace) Chuang, a Ph.D. candidate studying bioengineering and a Kummer Innovation & Entrepreneurship Doctoral Fellow, will present “uPAR-Targeted Dendrimer Nanoparticles for Inflammation Modulation and Plaque Stabilization in Atherosclerosis.” Her research focuses on developing dendrimer-based nanoparticle drug and gene delivery systems for the treatment of cancer and atherosclerosis, with an emphasis on translating laboratory discoveries into clinical applications.